Article and Video CATEGORIES

Cancer Journey

Search By

Amy brings over three decades of experience in for-profit and nonprofit business management and ownership. In December 2017, she joined The Global Resource for Advancing Cancer Education as its Executive Director. She directs its growth in strategy, revenue, outreach, partnership, and programs.

 

August 2019 Volunteer of the Month - Dan Laubhan!
GRACE is so honored to work alongside some exceptional volunteers. This month we recognize our friend Dan Laubhan!
Author
Amy Bickleman
Image
We couldn't do what we do without you, our volunteers! 

From helping at the ASCO booth, admin and transcription work, to spreading pamphlets and information about GRACE, we have been lucky enough to meet some of the most amazing people.

This month we are pleased to give a gracious nod and a huge thank you to Dan Laubhan.  We first met Dan at ASCO when he offered to help us work the booth at the yearly Chicago event. 

GRACE volunteer Dan Laubhan's day job is practicing transactional law as a Director and Senior Counsel for Discover Financial Services, where he has worked for 13 years. He was introduced to GRACE in the course of his wife Maria's struggle with non-small cell lung cancer, which was diagnosed as stage 4 in 2010. Prior to losing Maria in 2017, both Dan and Maria were daily users of GRACE's resources and came to know many of us here at GRACE. In light of Maria's EGFR status, Dan reached out to GRACE faculty member Dr. Lecia Sequist of Massachusetts General Hospital, who they were introduced to through GRACE. They subsequently worked with both their local GRACE faculty member, Dr. Thomas Hensing, and Dr. Sequist to assure that Maria had the best medical counsel available. Subsequently, Dan has continued to work with GRACE, volunteering to work at the GRACE booth each year at ASCO in Chicago and singing GRACE's praises to both visitors to the booth and other friends, family and colleagues who come to need guidance on various aspects of cancer care.

In the course of Maria's illness, Dan will tell you that in addition to the incredible value of targeted therapies and immunotherapies that have been developed and which also remain under development, he was struck by the power of the love offered and displayed by so many people over the course of their family's bout with cancer... easing cancer's burdens that their family were required to deal with. It made all the difference.

On his off-time, Dan enjoys traveling, studying American history, including the U.S. Civil War and is a proponent of the new urbanism movement. He and his 14-year old son, Daniel, live in a conservation community in Grayslake, IL.


Dan - We love you.  You have been such a help to us during our times in Chicago -- and we so appreciate your kind words and are humbled that we could help in any way during your journey.  We are GRACE because of people like you. 

The GRACE Staff

 

***would you like to volunteer with GRACE?  Fill out this volunteer form and a member of our team will get back to you! 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on